Clindamycin Phosphate
FDA-approved product (injectable, injection), marketed as Cleocin, Cleocin Phosphate, Cleocin Phosphate In Dextrose 5% In Plastic Container and 12 more.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 1 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Abdominal abscess
- Abscess
- Acne
- Bacterial disease
- Bacterial vaginosis
- Empyema
- Endometritis
- Female reproductive system disease
- Infection
- Irritable bowel syndrome
- Lung Abscess
- Osteomyelitis
- Parametritis
- Peritonitis
- Pneumonia
- Pseudomembranous enterocolitis
- and 3 more
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Antiinfectives for treatment of acne; Antibiotics; Lincosamides
- Anti-infective classification
- Classified as an existing antimicrobial.WHO ATC D10AF01; WHO ATC J01FF01; WHO ATC G01AA10
Repurposing investigation
Clindamycin Phosphate is already an antimicrobial, so it is not counted among the repurposing candidates. Its AI-predicted activity is shown below for reference.
AI-predicted activity
AI prediction · nothing measured- MRSA58.8% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli18.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae19.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis27.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Clindamycin Phosphate with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- UrsodiolExisting use: Biliary liver cirrhosis, Primary biliary cirrhosis69.2% AI-predicted activityagainst MRSA50+ registered studies
- OlaparibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 9 more69.2% AI-predicted activityagainst MRSA50+ registered studies
- Ganirelix AcetateExisting use: Female infertility, Positive regulation of ovulation, Reproductive Techniques, Assisted69.1% AI-predicted activityagainst MRSA50+ registered studies
- DanicopanExisting use: Acquired paroxysmal nocturnal hemoglobinuria, Hemoglobinuria, Paroxysmal, Hemolysis68.7% AI-predicted activityagainst MRSA30 registered studies
- Simeprevir SodiumExisting use: Chronic hepatitis C virus infection68.6% AI-predicted activityagainst MRSANo documented evidence found
- Lanreotide AcetateExisting use: Acromegaly, Carcinoid syndrome68.3% AI-predicted activityagainst MRSA50+ registered studies
- Cholic AcidExisting use: Abnormality of the gastrointestinal tract, Inborn errors of metabolism, Liver disease and 1 more68.0% AI-predicted activityagainst MRSA50+ registered studies
- EptifibatideExisting use: Acute coronary syndrome, Acute myocardial infarction, Intermediate coronary syndrome and 2 more67.8% AI-predicted activityagainst MRSA35 registered studies
- AbarelixExisting use: Neoplasm67.7% AI-predicted activityagainst MRSA5 registered studies
- EverolimusExisting use: Adenoma sebaceum, Anaplastic astrocytoma, Angiomyolipoma and 18 more67.5% AI-predicted activityagainst MRSA50+ registered studies
- Paliperidone PalmitateExisting use: Mental or behavioural disorder, Psychosis, Schizoaffective disorder and 1 more67.3% AI-predicted activityagainst MRSA50+ registered studies
- PaliperidoneExisting use: Mental or behavioural disorder, Psychosis, Schizoaffective disorder and 1 more67.2% AI-predicted activityagainst MRSA50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Does Antibiotic Prophylaxis Reduce Wound Complications After Vulvar Excision of Premalignant Lesions
NCT03578965 · start 2018-07-13
Registered record
- Registry ID
- NCT03578965
- Conditions
- Premalignant Vulvar Lesion; Benign Vulvar Lesion
- Interventions
- Cefazolin
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2018-07-13
- Completion
- 2021-11-23
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPremalignant Vulvar Lesion; Benign Vulvar LesionInterventionCefazolinPhasePhase 2Registry statusCompletedA Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
NCT04516148 · start 2018-05-29
Registered record
- Registry ID
- NCT04516148
- Conditions
- Burn; Surgery; Infection Wound
- Interventions
- Cefazolin; Clindamycin
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2018-05-29
- Completion
- 2020-10-30
- Enrolment
- 32
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBurn; Surgery; Infection WoundInterventionCefazolin; ClindamycinPhasePhase 4Registry statusCompletedAntibiotics During Intrauterine Balloon Tamponade Placement
NCT03478163 · start 2018-03-08
Registered record
- Registry ID
- NCT03478163
- Conditions
- Obstetric Complication; Postpartum Hemorrhage; Postpartum Endometritis
- Interventions
- CeFAZolin 1000 MG; Clindamycin 900 MG in 6 ML Injection
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Terminated
- Start
- 2018-03-08
- Completion
- 2021-05-03
- Enrolment
- 11
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionObstetric Complication; Postpartum Hemorrhage; Postpartum EndometritisInterventionCeFAZolin 1000 MG; Clindamycin 900 MG in 6 ML InjectionPhasePhase 4Registry statusTerminatedChlorhexidine Vaginal Cleansing Versus Iodine Prior to C-section and the Rate of Postoperative Infection
NCT03431701 · start 2018-02-08
Registered record
- Registry ID
- NCT03431701
- Conditions
- Vaginal Scrubbing
- Interventions
- Chlorhexidine; Iodine; Antibiotics
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2018-02-08
- Completion
- 2019-06-30
- Enrolment
- 333
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVaginal ScrubbingInterventionChlorhexidine; Iodine; AntibioticsPhaseNot applicableRegistry statusCompletedPeritonsillar Abscess: Aspiration Versus Tonsillectomy a Chaud
NCT03326661 · start 2017-11-10
Registered record
- Registry ID
- NCT03326661
- Conditions
- Peritonsillar Abscess
- Interventions
- Aspiration; Tonsillectomy a chaud; Penicillin V + metronidazol (Penicillin allergy: Clindamycin alone)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2017-11-10
- Completion
- 2020-11-30
- Enrolment
- 128
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPeritonsillar AbscessInterventionAspiration; Tonsillectomy a chaud; Penicillin V + metronidazol (Penicillin allergy: Clindamycin alone)PhaseNot applicableRegistry statusUnknownAntibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS)
NCT03261830 · start 2017-08-18
Registered record
- Registry ID
- NCT03261830
- Conditions
- Supracondylar Humerus Fracture; Post Operative Wound Infection
- Interventions
- Cefazolin; Clindamycin; Saline
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2017-08-18
- Completion
- 2023-03-10
- Enrolment
- 160
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSupracondylar Humerus Fracture; Post Operative Wound InfectionInterventionCefazolin; Clindamycin; SalinePhasePhase 4Registry statusCompletedTarget Attainment and Pharmacokinetics of Antimicrobials in Non-critically Ill Surgery Patients (TAPAS)
NCT03120663 · start 2016-11-30
Registered record
- Registry ID
- NCT03120663
- Conditions
- Surgery
- Interventions
- amoxicillin-clavulanic acid
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2016-11-30
- Completion
- 2018-09-30
- Enrolment
- 120
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSurgeryInterventionamoxicillin-clavulanic acidPhaseNot recordedRegistry statusUnknownOral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study
NCT02795845 · start 2016-11
Registered record
- Registry ID
- NCT02795845
- Conditions
- Bacterial Vaginosis and Vaginal Candidiasis At Pregnancy
- Interventions
- Probiotic Capsule containing L. acidophilus, L. Paracasei, L. Rhamnosus, streptococcus thermophilus and Bifidobacterium bifidum; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2016-11
- Completion
- 2021-08
- Enrolment
- 157
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBacterial Vaginosis and Vaginal Candidiasis At PregnancyInterventionProbiotic Capsule containing L. acidophilus, L. Paracasei, L. Rhamnosus, streptococcus thermophilus and Bifidobacterium bifidum; PlaceboPhaseNot applicableRegistry statusCompletedVaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis
NCT03234517 · start 2016-08-01
Registered record
- Registry ID
- NCT03234517
- Conditions
- Bacterial Vaginosis Treatment
- Interventions
- Vaginal Clindamycin Cream; Vaginal Probiotic
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Unknown
- Start
- 2016-08-01
- Completion
- 2018-08
- Enrolment
- 200
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBacterial Vaginosis TreatmentInterventionVaginal Clindamycin Cream; Vaginal ProbioticPhasePhase 2Registry statusUnknownThe Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis
NCT03080740 · start 2016-07
Registered record
- Registry ID
- NCT03080740
- Conditions
- Bacterial Vaginosis
- Interventions
- Clindamycin palmitate hydrochloride dispersible tablet; Metronidazole Tablet
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2016-07
- Completion
- 2017-12
- Enrolment
- 300
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBacterial VaginosisInterventionClindamycin palmitate hydrochloride dispersible tablet; Metronidazole TabletPhasePhase 4Registry statusUnknownEffect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal Ring
NCT02545452 · start 2015-09-15
Registered record
- Registry ID
- NCT02545452
- Conditions
- Endometriosis
- Interventions
- Anastrozole / Levonorgestrel (BAY98-7196); Gyno-Daktarin; Sobelin vaginal creme; Patentex oval; Tampon
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2015-09-15
- Completion
- 2016-07-29
- Enrolment
- 52
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionEndometriosisInterventionAnastrozole / Levonorgestrel (BAY98-7196); Gyno-Daktarin; Sobelin vaginal creme; Patentex oval +1 morePhasePhase 1Registry statusCompletedValidation of the Jawbone Anatomy Classification in Endosseous Dental Implant Treatment
NCT02054676 · start 2014-02
Registered record
- Registry ID
- NCT02054676
- Conditions
- Partially Edentulous Jaw
- Interventions
- Cone-Beam Computed Tomography preoperative evaluation.; Intraoperative edentulous jaw segment parameters evaluation.; Endosseous dental implant placement.; Dental implant position evaluation.; Medications.; Late postoperative soft tissue evaluation.
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2014-02
- Completion
- 2016-04
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPartially Edentulous JawInterventionCone-Beam Computed Tomography preoperative evaluation.; Intraoperative edentulous jaw segment parameters evaluation.; Endosseous dental implant placement.; Dental implant position evaluation. +2 morePhaseNot applicableRegistry statusUnknownClindamycin to Reduce Preterm Birth in a Low Resource Setting
NCT01800825 · start 2013-07
Registered record
- Registry ID
- NCT01800825
- Conditions
- Pregnancy; Prematurity; Preterm Birth; Bacterial Vaginosis
- Interventions
- Clindamycin; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2013-07
- Completion
- 2016-04
- Enrolment
- 1,726
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPregnancy; Prematurity; Preterm Birth; Bacterial VaginosisInterventionClindamycin; PlaceboPhasePhase 4Registry statusCompletedAUGMENTIN™ in Dental Infections
NCT02141217 · start 2013-03-21
Registered record
- Registry ID
- NCT02141217
- Conditions
- Focal Infection, Dental
- Interventions
- Amoxicillin/clavulanate; Clindamycin
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2013-03-21
- Completion
- 2013-12-28
- Enrolment
- 472
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionFocal Infection, DentalInterventionAmoxicillin/clavulanate; ClindamycinPhasePhase 4Registry statusCompletedGentamicin Versus Clindamycin Versus Normal Saline Lavage in Axilla
NCT02314806 · start 2013-01
Registered record
- Registry ID
- NCT02314806
- Conditions
- Breast Cancer
- Interventions
- Irrigation with gentamicin solution; Irrigation with Clindamycin solution; Irrigation with Normal saline
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2013-01
- Completion
- 2014-12
- Enrolment
- 51
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBreast CancerInterventionIrrigation with gentamicin solution; Irrigation with Clindamycin solution; Irrigation with Normal salinePhasePhase 3Registry statusCompleted